Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Wille-Jorgensen P, Syk I, Smedh K, et al. Effect of more vs less frequent follow-up testing on overall and colorectal cancer-specific mortality in patients with stage II or III colorectal cancer: the COLOFOL randomized clinical trial. JAMA. 2018 May 22;319(20):2095–2103.
   PubMed Web of Science ®Google Scholar
• Staib L, Link KH, Blatz A, et al. Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients–monoinstitutional experience. World J Surg. 2002 Jan;26(1):59–66.
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Cederquist L, et al. Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J National Compr Cancer Network. 2017;15(3):370–398.
   PubMed Web of Science ®Google Scholar
• Dolan RD, Laird BJA, Horgan PG, et al. The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: a systematic review. Crit Rev Oncol Hematol. 2018Dec;132:130–137.
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–545.
   PubMed Web of Science ®Google Scholar
• Sunakawa Y, Yang D, Cao S, et al. Immune-related genes to dominate neutrophil-lymphocyte ratio (nlr) associated with survival of cetuximab treatment in metastatic colorectal cancer. Clin Colorectal Cancer. 2018 Dec;17(4):e741–e749.
   PubMed Web of Science ®Google Scholar
• Li B, Zhou P, Liu Y, et al. Platelet-to-lymphocyte ratio in advanced cancer: review and meta-analysis. Clin Chim Acta. 2018Aug;483:48–56.
   PubMed Web of Science ®Google Scholar
• Tsujino T, Komura K, Hashimoto T, et al. C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma - A data from multi-institutional study in Japan. Urol Oncol Semin Original Invest. 2019 Nov;37(11):812e1–812 e8.
   Web of Science ®Google Scholar
• Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004 Nov 19;279(47):48487–48490.
   PubMed Web of Science ®Google Scholar
• Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011 Jul-Aug;48(4):155–170.
   PubMed Web of Science ®Google Scholar
• Heikkila K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health. 2007 Sep;61(9):824–832.
   PubMed Web of Science ®Google Scholar
• Pathak S, Nunes QM, Daniels IR, et al. Is C-reactive protein useful in prognostication for colorectal cancer? A systematic review. Colorectal Dis. 2014 Oct;16(10):769–776.
   PubMed Web of Science ®Google Scholar
• Polterauer S, Grimm C, Tempfer C, et al. C-reactive protein is a prognostic parameter in patients with cervical cancer. Gynecol Oncol. 2007 Oct;107(1):114–117.
   PubMed Web of Science ®Google Scholar
• Lamb GW, McMillan DC, Ramsey S, et al. The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer. Br J Cancer. 2006 Mar 27;94(6):781–784.
   PubMed Web of Science ®Google Scholar
• Huang J, Baum Y, Alemozaffar M, et al. C-reactive protein in urologic cancers. Mol Aspects Med. 2015Nov;45:28–36.
   PubMed Web of Science ®Google Scholar
• Xiao X, Wang S, Long G. C-reactive protein is a significant predictor of improved survival in patients with advanced non-small cell lung cancer. Medicine (Baltimore). 2019 Jun;98(26):e16238.
   PubMed Web of Science ®Google Scholar
• Frydenberg H, Thune I, Lofterod T, et al. Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival. Breast Cancer Res Treat. 2016 Jan;155(2):345–354.
   PubMed Web of Science ®Google Scholar
• Oh SY, Heo J, Noh OK, et al. Absolute lymphocyte count in preoperative chemoradiotherapy for rectal cancer: changes over time and prognostic significance. Technol Cancer Res Treat. 2018 Jan 1;17: 1533033818780065.
   Web of Science ®Google Scholar
• Araki K, Ito Y, Fukada I, et al. Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel. BMC Cancer. 2018 Oct 16;18(1):982.
   PubMedGoogle Scholar
• Suzuki R, Wei X, Allen PK, et al. Prognostic significance of total lymphocyte count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio in limited-stage small-cell lung cancer. Clin Lung Cancer. 2019 Mar;20(2):117–123.
   PubMed Web of Science ®Google Scholar
• Menetrier-Caux C, Ray-Coquard I, Blay JY, et al. Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with cytokines? J Immunother Cancer. 2019 Mar 28;7(1):85.
   PubMedGoogle Scholar
• Edge SB, Compton CC. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010 Jun;17(6):1471–1474.
   PubMed Web of Science ®Google Scholar
• Macfarland TW. Student’s t-test for independent samples. Springer International Publishing; 2014.
   Google Scholar
• McHugh ML. The Chi-square test of independence. Biochem Med (Zagreb). 2013;23(2):143–149.
   PubMed Web of Science ®Google Scholar
• Palazzo M, Templeton M. Statistical interpretation of Kaplan–Meier curves. Intensive Care Med. 2007;33(12):2235.
   PubMed Web of Science ®Google Scholar
• Hopkins A Logrank Test. Wiley Encyclopedia of Clinical Trials; 2008.
   Google Scholar
• Sushil M, David M, Burd RS, et al. High-dimensional, massive sample-size Cox proportional hazards regression for survival analysis. Biostats. 2014;15(2):207–221.
   PubMed Web of Science ®Google Scholar
• Hothorn T, Zeileis A. Generalized maximally selected statistics. Biometrics. 2008 Dec;64(4):1263–1269.
   PubMed Web of Science ®Google Scholar
• Chai EZ, Siveen KS, Shanmugam MK, et al. Analysis of the intricate relationship between chronic inflammation and cancer. Biochem J. 2015 May 15;468(1):1–15.
   PubMedGoogle Scholar
• Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007 May;117(5):1175–1183.
   PubMed Web of Science ®Google Scholar
• Lee MS, Menter DG, Kopetz S. Right versus left colon cancer biology: integrating the consensus molecular subtypes. J National Compr Cancer Network. 2017;15(3):411–419.
   PubMed Web of Science ®Google Scholar
• Huang X, Liu J, Mo X, et al. Systematic profiling of alternative splicing events and splicing factors in left- and right-sided colon cancer. Aging (Albany NY). 2019;11(19):8270–8293.
   PubMedGoogle Scholar